Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0FB1Q
|
|||
| Drug Name |
PMID25656651-Compound-31b
|
|||
| Drug Type |
Small molecular drug
|
|||
| Company |
NOVARTIS AG BURGER, Matthew DING, Yu HAN, Wooseok LINDVALL, Mika NISHIGUCHI, Gisele A. RICO, Alice SMITH, Aaron TANNER, Huw WAN, Lifeng
|
|||
| Structure |
 |
Download2D MOL |
||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Fusion protein Bcr-Abl T315I mutant (Bcr-Abl T315I) | Target Info | Inhibitor | [1] |
| Target's Patent Info | Fusion protein Bcr-Abl T315I mutant (Bcr-Abl T315I) | Target's Patent Info | [1] | |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Bcr-Abl tyrosine kinase inhibitors: a patent review.Expert Opin Ther Pat. 2015 Apr;25(4):397-412. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.